JP2001512443A - アルギニンケイ酸塩イノシトール錯体及びその使用 - Google Patents

アルギニンケイ酸塩イノシトール錯体及びその使用

Info

Publication number
JP2001512443A
JP2001512443A JP53496698A JP53496698A JP2001512443A JP 2001512443 A JP2001512443 A JP 2001512443A JP 53496698 A JP53496698 A JP 53496698A JP 53496698 A JP53496698 A JP 53496698A JP 2001512443 A JP2001512443 A JP 2001512443A
Authority
JP
Japan
Prior art keywords
arginine
complex
silicate
individual
inositol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP53496698A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001512443A5 (cg-RX-API-DMAC10.html
Inventor
マッカーティ,マーク
ジーリンスキイ,ジャン
Original Assignee
ニュートリション 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ニュートリション 21 filed Critical ニュートリション 21
Publication of JP2001512443A publication Critical patent/JP2001512443A/ja
Publication of JP2001512443A5 publication Critical patent/JP2001512443A5/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/04—Esters of silicic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP53496698A 1997-02-12 1998-02-11 アルギニンケイ酸塩イノシトール錯体及びその使用 Ceased JP2001512443A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/799,784 US5707970A (en) 1997-02-12 1997-02-12 Arginine silicate complex and use thereof
US08/799,784 1997-02-12
PCT/US1998/002443 WO1998034647A1 (en) 1997-02-12 1998-02-11 Arginine silicate inositol complex and use thereof

Publications (2)

Publication Number Publication Date
JP2001512443A true JP2001512443A (ja) 2001-08-21
JP2001512443A5 JP2001512443A5 (cg-RX-API-DMAC10.html) 2005-10-06

Family

ID=25176739

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53496698A Ceased JP2001512443A (ja) 1997-02-12 1998-02-11 アルギニンケイ酸塩イノシトール錯体及びその使用

Country Status (16)

Country Link
US (3) US5707970A (cg-RX-API-DMAC10.html)
EP (1) EP1007096B1 (cg-RX-API-DMAC10.html)
JP (1) JP2001512443A (cg-RX-API-DMAC10.html)
KR (1) KR20000070977A (cg-RX-API-DMAC10.html)
CN (1) CN1182873C (cg-RX-API-DMAC10.html)
AT (1) ATE251914T1 (cg-RX-API-DMAC10.html)
AU (1) AU722975B2 (cg-RX-API-DMAC10.html)
BR (1) BR9807675A (cg-RX-API-DMAC10.html)
CA (1) CA2279233A1 (cg-RX-API-DMAC10.html)
DE (1) DE69819016T2 (cg-RX-API-DMAC10.html)
DK (1) DK1007096T3 (cg-RX-API-DMAC10.html)
ES (1) ES2209112T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0001998A3 (cg-RX-API-DMAC10.html)
IL (1) IL130925A0 (cg-RX-API-DMAC10.html)
PT (1) PT1007096E (cg-RX-API-DMAC10.html)
WO (1) WO1998034647A1 (cg-RX-API-DMAC10.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012116844A (ja) * 2006-09-21 2012-06-21 Toshiki Oguro 硬組織再生促進剤
JP2022515314A (ja) * 2018-11-02 2022-02-18 ニュートリション・21,エルエルシー イノシトール安定化アルギニンケイ酸塩複合体及びイノシトールを含有するビデオゲームプレーヤーの認知機能を改善するための組成物

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707970A (en) 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
AU2001281337A1 (en) * 2000-07-24 2002-02-05 Nutrition 21, Inc. Arginine saccharate and use thereof
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
TWI300947B (en) * 2001-07-12 2008-09-11 Semiconductor Energy Lab Display device using electron source elements and method of driving same
AU2002360765C1 (en) * 2001-12-20 2009-06-11 Trivascular, Inc. Advanced endovascular graft
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
US20040097467A1 (en) * 2002-08-22 2004-05-20 Vijaya Juturu Arginine silicate inositol complex and use thereof
US6803456B1 (en) * 2003-08-13 2004-10-12 Rutherford Chemicals Llc Process for the production of arginine-silicate complex
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
CA2558573A1 (en) * 2004-03-11 2005-09-22 Trivascular, Inc. Modular endovascular graft
ES2323141T3 (es) * 2004-08-12 2009-07-07 Quest Pharmaceutical Services Composiciones farmaceuticas para el suministro por liberacion controlada de compuestos biologicamente activos.
US7919620B2 (en) * 2005-06-01 2011-04-05 Coral Biotech Kabushiki Kaisha Agent for suppressing blood pressure elevation
ITMI20060677A1 (it) * 2006-04-06 2007-10-07 Damor Farmaceutici Profarmaci dell'arginina ad elevata attivita'terapeutica
ES2579229T3 (es) 2007-03-13 2016-08-08 Jds Therapeutics, Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
GB0805279D0 (en) * 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
US20170000809A1 (en) * 2015-06-30 2017-01-05 Jds Therapeutics, Llc Arginine silicate inositol for improving cognitive function
CN107835778B (zh) 2015-07-13 2020-06-09 奥的斯电梯公司 阻遏装置抑制钥匙
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
AU2017217466A1 (en) 2016-02-11 2018-08-23 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
GB2568849B (en) 2016-09-01 2022-08-10 Nutrition 21 Llc Magnesium biotinate compositions and methods of use
GB2613672A (en) 2019-12-16 2023-06-14 Nutrition 21 Llc Methods of production of aginine-silicate complexes
CA3237984A1 (en) * 2021-11-12 2023-05-19 Nutrition21, LLC Compositions and methods for treating or preventing myopathy in poultry
CN118206406B (zh) * 2024-03-20 2025-08-15 山东农业大学 精氨酸硅酸盐肌醇络合物在提高作物果实品质中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4385052A (en) * 1981-07-20 1983-05-24 International Plant Research Institute, Inc. Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US5250569A (en) * 1991-04-22 1993-10-05 Godfrey Science & Design, Inc. Amino acid flavorings of aluminum astringent for oral use
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012116844A (ja) * 2006-09-21 2012-06-21 Toshiki Oguro 硬組織再生促進剤
JP2022515314A (ja) * 2018-11-02 2022-02-18 ニュートリション・21,エルエルシー イノシトール安定化アルギニンケイ酸塩複合体及びイノシトールを含有するビデオゲームプレーヤーの認知機能を改善するための組成物

Also Published As

Publication number Publication date
WO1998034647A1 (en) 1998-08-13
US6156735A (en) 2000-12-05
DE69819016D1 (de) 2003-11-20
ATE251914T1 (de) 2003-11-15
CN1182873C (zh) 2005-01-05
HUP0001998A2 (hu) 2000-10-28
EP1007096A1 (en) 2000-06-14
BR9807675A (pt) 2000-02-15
US6344444B1 (en) 2002-02-05
PT1007096E (pt) 2004-03-31
DE69819016T2 (de) 2004-04-29
ES2209112T3 (es) 2004-06-16
HUP0001998A3 (en) 2002-01-28
US5707970A (en) 1998-01-13
EP1007096B1 (en) 2003-10-15
DK1007096T3 (da) 2003-12-01
IL130925A0 (en) 2001-01-28
CA2279233A1 (en) 1998-08-13
AU6273798A (en) 1998-08-26
AU722975B2 (en) 2000-08-17
CN1246801A (zh) 2000-03-08
KR20000070977A (ko) 2000-11-25

Similar Documents

Publication Publication Date Title
AU722975B2 (en) Arginine silicate inositol complex and use thereof
AU717533B2 (en) Magnesium (-)hydroxycitrate, preparation process, uses and compositions, in particular pharmaceutical compositions, containing it
US5776504A (en) Magnesium taurate for prevention and treatment of pre-eclampsia/eclampsia
JPH08505141A (ja) コレステロール生合成阻害剤およびβ−ラクタムコレステロール吸収阻害剤の組合せ
JP4729161B2 (ja) 固体形状で、安定且つ濃縮した、生物学的に同化可能なオルト珪酸を含有する複合体及びその製造方法
US5776498A (en) Magnesium taurate as an adjuvant to rapid thrombolytic therapy
EP0280593B1 (fr) Composition à base d'acide aminé et de vitamines utilisable en thérapeutique cancérologique
MXPA99007232A (en) Arginine silicate inositol complex and use thereof
EP1100482A1 (fr) Utilisation des calix(n)arenes pour la fabrication d'un medicament pour le traitement des maladies fibrotiques
JP3035343B2 (ja) 腸内鉄吸収性を制御するための経口投与ポルフィリン類
JPH04230628A (ja) 脂質調節薬としての10員環ラクトンの使用
CZ278799A3 (cs) Arginin-silikát-inositolový komplex a jeho použití
JP2000510476A (ja) フェノール系殺生物剤およびコリンを含有する局所薬剤
FR2539413A1 (fr) Carbostyriloximinopropanolamines utiles comme medicaments et procede pour leur preparation
FR2624120A1 (fr) Nouveaux sels organogermaniques utiles comme medicaments notamment comme activateurs des osteoblastes
WO2002008175A2 (en) Arginine saccharate and use thereof
CA1227136A (fr) Compositions pharmaceutiques contenant a titre de principe actif l'acide 4-(benzofuran-2-yl)4-oxo buten-2-oique et/ou de ses sels pharmaceutiquement acceptables
JP2670081B2 (ja) 尿路結石抑制剤
NL7902233A (nl) Werkwijze voor het bereiden van een geneesmiddel voor het behandelen van niet-neoplastische obstructieve icterus.
JP2002538075A (ja) 太りすぎの治療および/または予防のための合成組成物およびその使用
MC200019A1 (fr) Complexe a base d'acide orthosilicique biologiquement assimilable se presentant sous forme solide stable et concentree et procede de preparation
JPH0541606B2 (cg-RX-API-DMAC10.html)
JPWO2001007077A1 (ja) 抗潰瘍剤

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050204

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060831

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080311

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20080805

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090421